Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Gynecol Oncol. 2022 Nov 21;168:76–82. doi: 10.1016/j.ygyno.2022.11.004

Figure 1: Antitumor activity of the combination of selinexor and weekly paclitaxel.

Figure 1:

Abbreviations: B = Breast cancer; O = Ovarian Cancer; P = Prostate Cancer; S = Squamous Cell Carcinoma of the Cervix; PR = Partial Response; SD = Stable Disease; PD = Progressive Disease